Pharmafile Logo
Pharmafocus logo
Advanced Search
liam_english_photo

EFPIA appoints comms head from Lilly

February 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, English, liam, lilly

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has hired its new comms director from Eli Lilly. Liam English …

Appointment
Jazz image

Jazz Pharma chooses Ireland for first facility

February 17, 2014
Manufacturing and Production API, Ireland, azur, jazz pharma

Jazz Pharmaceuticals will build its first in-house manufacturing facility in Ireland after years of relying on outsourcing to meet its …

News
Manufacturing image

Pharma manufacturing news in brief

February 17, 2014
Manufacturing and Production Advaxis, Alexion, Berkshire Sterile Manufacturing, Catalent, Hospira, Shire

Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …

News

Novartis pays out for US biotech

February 17, 2014
Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals

Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …

News

Aveo and Astellas part ways

February 17, 2014
Sales and Marketing Astellas, Aveo, Boehringer, EMA, tivozanib

Aveo Oncology and Astellas Pharma are to abandon their three-year old collaboration and licence agreement for investigational tyrosine kinase inhibitor …

News

NICE: new system will allow more drugs on NHS

February 17, 2014
Sales and Marketing DH, Dillon, DoH, NHS, NICE, QALY

NICE has said that it will be able to approve more medicines under a new drug pricing policy, but warns …

News
Germany image

Germany focus: strength with control

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE

Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …

Feature
graham_hetherington_shire

Shire chief financial officer steps down

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, hetherington

Shire’s chief financial officer (CFO) Graham Hetherington has notified the company of his decision to step down. Flemming Ornskov, Shire …

Appointment
gsk_through_window

Pharma’s reputation ‘getting worse’

February 17, 2014
Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation

The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …

News

‘Wraptac’ print your own label for the Clinical Trials Industry

February 14, 2014

News
Press release

‘More than 2,000’ US lawsuits for Boehringer

February 14, 2014
Sales and Marketing Boehringer, Pradaxa, Xarelto, blood thinner, warfarin

Boehringer Ingelheim is facing more than 2,000 lawsuits in the US over allegations that its stroke prevention pill Pradaxa has …

News
Stuart rose image

Former M&S chief executive to headhunt for NHS

February 14, 2014
Medical Communications, Sales and Marketing Dalton, Hunt, NHS, stuart rose, superheads

Health secretary Jeremy Hunt has appointed the man accredited with turning around the fortunes of Marks and Spencer to advise …

News
Shire HQ

Shire’s Vyvanse could bring in new revenue

February 14, 2014
Medical Communications, Research and Development, Sales and Marketing ADHD, Shire, Vyvanse, binge eating, generics

News
Pfizer image

Pfizer faces Australia action

February 14, 2014
Medical Communications, Sales and Marketing Australia, Lipitor, Pfizer, accc

Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …

News
capture

Emperra appoints new chief executive

February 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing e-health, emperra, krey

Healthcare development firm Emperra E-Health Technologies has hired Dr Christian Krey as managing director and chief executive. Krey was previously …

Appointment

Doctors highlight NHS data concerns

February 13, 2014
Medical Communications, Sales and Marketing NHS, RGCP, UK, care data, doctors

Senior doctors have voiced their worries about the public’s lack of preparedness for the government’s planned roll-out of patient data …

News
Janssen image

FDA extends licence for Janssen’s Imbruvica

February 13, 2014
Sales and Marketing FDA, Janssen, durect, imbruvica, leukaemia

Janssen and partner Pharmacyclics have been given an extended FDA approval for their new blood cancer treatment Imbruvica. The US …

News

Aesica hires director from Catalent

February 13, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, Catalent, muir

Contract development and manufacturing organisation (CDMO) Aesica has appointed Ian Muir to the newly-created position of commercial managing director. Muir’s …

Appointment
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News

NHS England savings ‘not used wisely’

February 12, 2014
Sales and Marketing England, NHS, QIPP, Simon Stevens, health select

A group of influential MPs has raised serious concerns over what the £10 billion worth of NHS England savings made …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026